Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Krishna Institute of Medical Sciences (NSE:KIMS) Cyclically Adjusted PS Ratio Explanation
Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.
Krishna Institute of Medical Sciences Cyclically Adjusted PS Ratio Related Terms
Krishna Institute of Medical Sciences Cyclically Adjusted PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Krishna Institute of Medical Sciences Cyclically Adjusted PS Ratio Chart
NSE:KIMS vs HCA, THC, EHC: Cyclically Adjusted PS Ratio Comparison
For the Medical Care Facilities subindustry, Krishna Institute of Medical Sciences's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Krishna Institute of Medical Sciences Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Krishna Institute of Medical Sciences's Cyclically Adjusted PS Ratio distribution charts can be found below:
* The bar in red indicates where Krishna Institute of Medical Sciences's Cyclically Adjusted PS Ratio falls into.
Krishna Institute of Medical Sciences Cyclically Adjusted PS Ratio Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.
Krishna Institute of Medical Sciences does not have a history long enough to calculate Cyclically Adjusted Revenue per Share. Therefore GuruFocus does not calculate Cyclically Adjusted PS Ratio for this company.
What does a Cyclically Adjusted PS Ratio of 14.24 mean?
Krishna Institute of Medical Sciences (NSE:KIMS) has a Cyclically Adjusted PS Ratio of 14.24 as of Sep. 17, 2026. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on Krishna Institute of Medical Sciences and its competitors. According to the industry distribution chart, Krishna Institute of Medical Sciences ranks #999999 out of 364 companies in the Healthcare Providers & Services industry.
Is Krishna Institute of Medical Sciences' Cyclically Adjusted PS Ratio too high?
Krishna Institute of Medical Sciences' current Cyclically Adjusted PS Ratio is 14.24. The Healthcare Providers & Services industry median Cyclically Adjusted PS Ratio is 1.18. Krishna Institute of Medical Sciences' value of 14.24 is 1106.8% above this industry median. Based on the distribution chart, Krishna Institute of Medical Sciences ranks #999999 out of 364 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Krishna Institute of Medical Sciences has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Krishna Institute of Medical Sciences' Cyclically Adjusted PS Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Krishna Institute of Medical Sciences ranks #999999 out of 364 companies for Cyclically Adjusted PS Ratio. This places Krishna Institute of Medical Sciences in the lower half of its industry. The industry median Cyclically Adjusted PS Ratio is 1.18. Krishna Institute of Medical Sciences' value of 14.24 is 1106.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PS Ratio for a Healthcare Providers & Services company?
The median Cyclically Adjusted PS Ratio among Healthcare Providers & Services companies is 1.18, based on 364 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Krishna Institute of Medical Sciences's current Cyclically Adjusted PS Ratio of 14.24 is 1106.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PS Ratio mean?
A high Cyclically Adjusted PS Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on Krishna Institute of Medical Sciences and its competitors. For the Healthcare Providers & Services industry, the median Cyclically Adjusted PS Ratio is 1.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Krishna Institute of Medical Sciences's current Cyclically Adjusted PS Ratio is 14.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krishna Institute of Medical Sciences stock overvalued right now?
Based on GuruFocus' analysis, Krishna Institute of Medical Sciences (NSE:KIMS) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹880.96, compared to a current price of ₹766.65 — trading 13% below its estimated fair value. The current Cyclically Adjusted PS Ratio is 14.24 and 1106.8% above the Healthcare Providers & Services industry median of 1.18. Krishna Institute of Medical Sciences' overall GF Score™ is 88/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PS Ratio calculated?
Cyclically Adjusted PS Ratio is calculated from a company's financial statements. For Krishna Institute of Medical Sciences (NSE:KIMS), the current Cyclically Adjusted PS Ratio is 14.24 as of Sep. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Krishna Institute of Medical Sciences (NSE:KIMS) Overvalued in 2026?
Based on GuruFocus' analysis, Krishna Institute of Medical Sciences stock appears to be undervalued.
The current stock price of ₹766.65 is trading 13% below its estimated GF Value™ of ₹880.96.
GuruFocus considers Krishna Institute of Medical Sciences to be Modestly Undervalued.
Key valuation signals for NSE:KIMS:
Cyclically Adjusted PS Ratio: 14.24
GF Value™: ₹880.96 vs. price of ₹766.65 (13% below fair value)
Industry Position: 1106.8% above the Healthcare Providers & Services median (#999999 of 364)
No single metric tells the full story. See the NSE:KIMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Krishna Institute of Medical Sciences Ltd is a healthcare group in Secunderabad and Telangana. It offers a comprehensive range of healthcare services, including oncology, cardiac sciences, neurosciences, gastric sciences, orthopedics, renal sciences, organ transplantation, mother and child care, and many more. The firm generates key revenue from Hospital services and Pharmacy.
88GF Score
Get the complete analysis for NSE:KIMS
Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:KIMS has been successfully added to your 
